Our findings are consistent with those of previous reports, which indicated that SALL4 levels were positively associated with lymph node metastasis and that SALL4 is an indicator of metastatic potential in GC (Zhang et al., 2018). The gene discussed is SALL4; the disease is metastatic malignant neoplasm in the lymph nodes.